Showing results (991-1000 of 6,500) with videos related to

Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|June 7, 2011
Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligandsBeatriz Sanchez-Correa, Sara Morgado, Inmaculada Gayoso, et al.
Cancer Immunology, Immunotherapy : CII|June 7, 2011
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancerSylvain Ladoire, François Martin, François Ghiringhelli
Cancer Immunology, Immunotherapy : CII|June 7, 2011
DNA fusion vaccines enter the clinicFreda K Stevenson, Ann Mander, Lindsey Chudley, et al.
Cancer Immunology, Immunotherapy : CII|March 10, 2011
MVA-5T4-induced immune responses are an early marker of efficacy in renal cancer patientsRichard Harrop, William H Shingler, Mike McDonald, et al.
Cancer Immunology, Immunotherapy : CII|March 3, 2011
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopesElse M Inderberg Suso, Svein Dueland, Anne-Marie Rasmussen, et al.
Cancer Immunology, Immunotherapy : CII|March 15, 2011
Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicityMónica Bernal, Angel Concha, Pablo Sáenz-López, et al.
Cancer Immunology, Immunotherapy : CII|March 15, 2011
Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancerKristin H Haraldsdóttir, Kjell Ivarsson, Karin Jansner, et al.
Cancer Immunology, Immunotherapy : CII|August 12, 2011
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacyRiccardo Danielli, Ruggero Ridolfi, Vanna Chiarion-Sileni, et al.
Cancer Immunology, Immunotherapy : CII|April 5, 2011
Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancerRaluca A Budiu, Gina Mantia-Smaldone, Esther Elishaev, et al.
Cancer Immunology, Immunotherapy : CII|March 29, 2011
Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinomaTatiana Salles de Souza Malaspina, Thaís Helena Gasparoto, Maria Renata Sales Nogueira Costa, et al.
Pageof 650